#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA655315	F	Minimum inhibitory concentration required to reduce cytomegalo virus (CMV (AD-169)) virus-induced cytopathicity by 50%	Cytomegalovirus	11		organism-based format	Scientific Literature
2.	ALA655316	F	Minimum inhibitory concentration required to reduce cytomegalo virus (CMV (Davis)) virus-induced cytopathicity by 50%	Cytomegalovirus	11		organism-based format	Scientific Literature
3.	ALA875903	F	Minimum inhibitory concentration required to reduce virus-induced cell growth by 50%	Homo sapiens	11		assay format	Scientific Literature
4.	ALA857209	F	Minimum inhibitory concentration required to reduce herpes simplex virus-1 (HSV-1 (F)) virus-induced cytopathicity by 50%	Human alphaherpesvirus 1	9		organism-based format	Scientific Literature
5.	ALA691850	F	Minimum inhibitory concentration required to reduce herpes simplex virus-1 (HSV-1 (KOS)) virus-induced cytopathicity by 50%	Human alphaherpesvirus 1	13		organism-based format	Scientific Literature
6.	ALA691851	F	Minimum inhibitory concentration required to reduce herpes simplex virus-1 (HSV-1 (McIntyre)) virus-induced cytopathicity by 50%	Human alphaherpesvirus 1	9		organism-based format	Scientific Literature
7.	ALA880020	F	Minimum inhibitory concentration required to reduce herpes simplex virus-2 (HSV-2 (196)) virus-induced cytopathicity by 50%	Human alphaherpesvirus 2	9		organism-based format	Scientific Literature
8.	ALA692370	F	Minimum inhibitory concentration required to reduce herpes simplex virus-2 (HSV-2 (G)) virus-induced cytopathicity by 50%	Human alphaherpesvirus 2	13		organism-based format	Scientific Literature
9.	ALA692371	F	Minimum inhibitory concentration required to reduce herpes simplex virus-2 (HSV-2 (Lyons)) virus-induced cytopathicity by 50%	Human alphaherpesvirus 2	9		organism-based format	Scientific Literature
10.	ALA810190	F	Minimum inhibitory concentration required to reduce thymidine kinase deficient-HSV-1 (B2006) virus-induced cytopathicity by 50%	Human alphaherpesvirus 1	8		organism-based format	Scientific Literature
11.	ALA810191	F	Minimum inhibitory concentration required to reduce thymidine kinase deficient-HSV-1 (VMW 1837) virus-induced cytopathicity by 50%	Human alphaherpesvirus 1	9		organism-based format	Scientific Literature
12.	ALA810192	F	Minimum inhibitory concentration required to reduce TK-VZV (07-1) virus-induced cytopathicity by 50%	Human alphaherpesvirus 3	12		organism-based format	Scientific Literature
13.	ALA810193	F	Minimum inhibitory concentration required to reduce TK-VZV (YS/R) virus-induced cytopathicity by 50%	Human alphaherpesvirus 3	13		organism-based format	Scientific Literature
14.	ALA816092	B	Binding affinity towards HSV-1 thymidine kinase		18		single protein format	Scientific Literature
15.	ALA816364	F	Minimum inhibitory concentration required to reduce VSV virus-induced cytopathicity by 50%	Vesicular stomatitis virus	13		organism-based format	Scientific Literature
16.	ALA816365	F	Minimum inhibitory concentration required to reduce vesicular somatitis virus (VSV (YS)) virus-induced cytopathicity by 50%	Vesicular stomatitis virus	12		organism-based format	Scientific Literature
17.	ALA816374	F	Minimum inhibitory concentration required to reduce vaccinia virus (VV) virus-induced cytopathicity by 50%	Vaccinia virus	13		organism-based format	Scientific Literature
18.	ALA824528	F	Minimum inhibitory concentration required to reduce Varicella-Zoster virus (VZV (Oka)) virus-induced cytopathicity by 50%	Human alphaherpesvirus 3	13		organism-based format	Scientific Literature
19.	ALA824223	F	Minimum concentration required to cause a microscopically detectable alteration of human cells morphology	Homo sapiens	3		cell-based format	Scientific Literature